Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Raza, A., Galili, N., Smith, S., Godwin, J. E., Boccia, R., Myint, H., … Sekeres, M. A. (2010). Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS). Blood, 116(21), 2910–2910. https://doi.org/10.1182/blood.v116.21.2910.2910